SCHEMBL20110010

SCHEMBL20110010

COc1ccc(OC)c(-c2cc(-c3ccccc3)ccc2F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ MAPK1 P28482 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ HDAC4 P56524 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ HDAC8 Q9BY41 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CYP11B1 P15538 1/20 0.44
▸ CYP11B2 P19099 1/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2E1 P05181 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C8 P10632 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18382934 0.88 L3MBTL1 (0.51) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL8501330 0.82 L3MBTL1 (0.60) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL10227330 0.82 ACLY (0.45) CYP1A1CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL4970050 0.81 HDAC4 (0.50) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL28588853 0.81 HDAC4 (0.58) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL17504869 0.81 FFAR1 (0.50) L3MBTL1KDM4EMAPK1RECQLHDAC8
SCHEMBL18382939 0.80 KDM4E (0.49) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL29572032 0.79 KDM4E (0.64) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL835688 0.79 KDM4E (0.64) L3MBTL1KDM4EMAPK1RECQLHDAC4
SCHEMBL29386715 0.78 KDM4E (0.59) L3MBTL1KDM4EMAPK1RECQLHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693084-B2 Compound for organic light-emitting device and organic light-emitting device including same SFC CO., LTD. (KR) 2020-06-23 — — US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 — — US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10693084-B2 Compound for organic light-emitting device and organic light-emitting device including same CYP1B1, CYP1A1, CRY2 L3MBTL1 161/4885KDM4E 3475/4885MAPK1 2328/4885
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CYP1B1, CYP1A1, CRY2 L3MBTL1 161/4885KDM4E 3475/4885MAPK1 2328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback